Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

Rat THY1 Protein (His Tag)

Sino Biological Inc. liefert Rat THY1 Protein (His Tag) mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über Rat THY1 Protein (His Tag) lesen Sie bitte: http://www.sinobiological.com/THY1-Protein-g-10045.html

Produkt-Information von THY1 Protein

Synonym THY1, Thy-1
Protein Construction

A DNA sequence encoding the rat THY1 (P01830)(Met1-Lys129) was expressed with a polyhistidine tag at the C-terminus.

Source Rat
Expression Host Human Cells

QC Testing von THY1 Protein

Purity > 95 % as determined by SDS-PAGE SDS-PAGE:
SDS-PAGE

THY1 protein

Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method
Stability Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal Gln 20
Molecular Mass

The recombinant rat THY1 comprises 121 amino acids and predicts a molecular mass of 14.1 kDa. The apparent molecular mass of  the recombinant protein is approximately 27-29 kDa in SDS-PAGE under reducing conditions due to glycosylation.

Formulation Lyophilized from sterile PBS, pH7.4.
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.

Usage Guide von THY1 Protein

Storage Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

Verwandte Produkte & Themen von THY1 Protein

Related Areas:

Biomarkers>>Neuronal Cell Markers>>CD90/THY-1

Immunology>>Adaptive Immunity>>Costimulation & Costimulatory Molecule>>CD90/THY-1

Immunology>>Cluster of Differentiation>>Hematopoietic Stem Cell CD Marker>>CD90/THY-1

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CD90/THY-1 Mouse CD90/THY1 Protein, Recombinant 50461-M08H
CD90/THY-1 Rat THY1 Protein, Recombinant 80337-R08H
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Mouse
CD90/THY-1
WB, ELISA CD90/THY-1 Antibody, Rabbit PAb 50461-RP01
Mouse
CD90/THY-1
WB, ELISA CD90/THY-1 Antibody, Rabbit PAb (Antigen Affinity Purified) 50461-RP02

Beschreibung von THY1 Protein

Thy-1 membrane glycoprotein, also known as Thy-1 antigen, CD90 and THY1, is a cell membrane protein which contains 1 Ig-like V-type (immunoglobulin-like) domain. THY1 / CD90, a member of the immunoglobulin superfamily of adhesion molecules with constitutive expression on fibroblast cells. THY1 / CD90 is a cell surface glycoprotein originally identified on mouse thymocytes. It has been identified on a variety of stem cells and at varying levels in non-lymphoid tissues such as on fibroblasts, brain cells, and activated endothelial cells. THY1 / CD90 is a membrane glycoprotein expressed in thymus, retinal ganglionic cells, and several types of stem cells. It was observed that THY1 / CD90 cell surface expression decreased significantly during the course of infection. In adult rats, expression of THY1 / CD90 on the B cell lineage is confined to immature B cells. The expression of THY1 / CD90 on neonatal MZ-B cells may have implications for their responsiveness to polysaccharide (T cell-independent type 2) antigens. THY1 / CD90 is modulated following infection with Human cytomegalovirus (HCMV). Neuroblastoma (NBL) is the most common solid tumor in children. THY1 / CD90 seemed to be a marker with a specific prognostic value in NBL patients. THY1 / CD90 may also play a role in cell-cell or cell-ligand interactions during synaptogenesis and other events in the brain.

References

  1. Dammers PM. et al., 2002, Dev Immunol. 9 (4): 187-95.
  2. Leis M. et al., 2004, J Gen Virol. 85 (7): 1995-2000.
  3. Wiesmann A. et al., 2006, Head Face Med. 2: 8.
  4. Fiegel HC. et al., 2008, Pediatr Surg Int. 24 (1): 101-5.
  5. Kisselbach L. et al., 2009, Cytotechnology. 59 (1): 31-44.
Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post